MA44092B1 - Nouveaux composés de succinate perméables à travers les cellules - Google Patents
Nouveaux composés de succinate perméables à travers les cellulesInfo
- Publication number
- MA44092B1 MA44092B1 MA44092A MA44092A MA44092B1 MA 44092 B1 MA44092 B1 MA 44092B1 MA 44092 A MA44092 A MA 44092A MA 44092 A MA44092 A MA 44092A MA 44092 B1 MA44092 B1 MA 44092B1
- Authority
- MA
- Morocco
- Prior art keywords
- permeable
- cell
- cells
- succinates
- succinate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/20—Esters of monothiocarboxylic acids
- C07C327/32—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
- C07C327/34—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups with amino groups bound to the same hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/20—Esters of monothiocarboxylic acids
- C07C327/28—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/20—Esters of monothiocarboxylic acids
- C07C327/30—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/20—Esters of monothiocarboxylic acids
- C07C327/32—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C07D211/76—Oxygen atoms attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/18—Eight-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
La présente invention concerne de nouveaux succinates perméables aux cellules et des précurseurs de succinate perméables aux cellules destinés à augmenter la production d'atp dans les mitochondries. La majeure partie de l'atp produit et utilisé dans la cellule eucaryote provient de la phosphorylation oxydative mitochondriale, un processus auquel des électrons de haute énergie sont fournis par le cycle de kreb. Tous les intermédiaires du cycle de kreb ne sont pas facilement perméables à la membrane cellulaire, l'un d'eux étant le succinate. La fourniture des nouveaux succinates perméables aux cellules est envisagée pour permettre le passage sur la membrane cellulaire et ainsi les succinates perméables aux cellules peuvent être utilisés pour améliorer la production d'atp mitochondriale.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA201470190 | 2014-04-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA44092B1 true MA44092B1 (fr) | 2023-08-31 |
Family
ID=58804197
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA39855A MA39855B1 (fr) | 2014-04-08 | 2015-04-08 | Nouveaux composés de succinate perméables à travers les cellules |
MA44092A MA44092B1 (fr) | 2014-04-08 | 2015-04-08 | Nouveaux composés de succinate perméables à travers les cellules |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA39855A MA39855B1 (fr) | 2014-04-08 | 2015-04-08 | Nouveaux composés de succinate perméables à travers les cellules |
Country Status (25)
Country | Link |
---|---|
US (2) | US11147789B2 (fr) |
EP (2) | EP3391941B1 (fr) |
JP (4) | JP7082861B6 (fr) |
KR (1) | KR102322543B1 (fr) |
CN (1) | CN106458957B (fr) |
AU (2) | AU2015243346C9 (fr) |
CA (1) | CA2944565C (fr) |
CY (1) | CY1120650T1 (fr) |
DK (1) | DK3129016T3 (fr) |
EA (1) | EA035678B1 (fr) |
ES (2) | ES2683860T3 (fr) |
HK (1) | HK1255109A1 (fr) |
HR (1) | HRP20181126T1 (fr) |
IL (1) | IL247904B (fr) |
LT (2) | LT3391941T (fr) |
MA (2) | MA39855B1 (fr) |
MX (1) | MX2016012691A (fr) |
PL (1) | PL3129016T3 (fr) |
PT (2) | PT3129016T (fr) |
RS (1) | RS57624B1 (fr) |
SG (1) | SG11201607907PA (fr) |
SI (1) | SI3129016T1 (fr) |
TR (1) | TR201810411T4 (fr) |
WO (1) | WO2015155231A1 (fr) |
ZA (1) | ZA201606608B (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3129364A1 (fr) * | 2014-04-08 | 2017-02-15 | Neurovive Pharmaceutical AB | Promédicaments d'acide succinique pour augmenter la production d'atp |
RS57624B1 (sr) * | 2014-04-08 | 2018-11-30 | Neurovive Pharmaceutical Ab | Nova sukcinatna jedinjenja koja prodiru u ćelije |
US10307389B2 (en) | 2014-04-08 | 2019-06-04 | Neurovive Pharmaceutical Ab | Succinate prodrugs for use in the treatment of lactic acidosis or drug-induced side-effects due to Complex I-related impairment of mitochondrial oxidative phosphorylation |
WO2017060400A1 (fr) * | 2015-10-07 | 2017-04-13 | Neurovive Pharmaceutical Ab | Métabolites protégés à base d'acide carboxylique pour le traitement des maladies liées à des dysfonctions mitochondriales |
WO2017060418A1 (fr) * | 2015-10-07 | 2017-04-13 | Neurovive Pharmaceutical Ab | Métabolites protégés à base d'acide carboxylique pour le traitement des maladies liées aux mitochondries |
WO2017060422A1 (fr) * | 2015-10-07 | 2017-04-13 | Neurovive Pharmaceutical Ab | Métabolites protégés à base d'acide carboxylique pour le traitement des troubles mitochondriaux |
WO2017096270A1 (fr) * | 2015-12-03 | 2017-06-08 | The Regents Of The University Of California | Méthodes de traitement de maladies mitochondriales |
JP2022504584A (ja) * | 2018-10-11 | 2022-01-13 | インブリア ファーマシューティカルズ, インコーポレイテッド | Tca回路中間体およびその使用方法 |
EP3863596A4 (fr) * | 2018-10-11 | 2022-08-10 | Imbria Pharmaceuticals, Inc. | Compositions et procédés de traitement et de prévention de la neuropathie optique héréditaire de leber |
CN109675037B (zh) * | 2019-01-25 | 2021-09-14 | 南方医科大学 | Atp及其受体在制备治疗自闭症药物中的应用 |
MA56506A (fr) * | 2019-06-19 | 2022-04-27 | Abliva Ab | Promédicamentà base de succinate, compositions contenant le promédicament de succinate et utilisations associées |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB756422A (en) * | 1950-09-14 | 1956-09-05 | Saint Gobain | Esters of urethanes of glycols and the manufacture thereof |
NL6806584A (fr) * | 1965-09-20 | 1968-11-12 | ||
FR2265355B1 (fr) * | 1974-03-28 | 1977-11-04 | Blum Jean | |
US5112953A (en) * | 1989-12-29 | 1992-05-12 | Neorx Corporation | Radiolabeled proteins for diagnostic or therapeutic use |
DE4101158C2 (de) * | 1991-01-14 | 1994-06-23 | Dainippon Ink & Chemicals | Wärmehärtbare Reaktionsharzgemische, Verwendung der erfindungsgemäßen Reaktionsharze zur Herstellung von Formkörpern und Beschichtungen |
WO1993015729A1 (fr) | 1992-02-07 | 1993-08-19 | Tsumura & Co. | Agent d'attenuation des effets secondaires |
JPH07331262A (ja) * | 1994-05-31 | 1995-12-19 | Tonen Corp | パティキュレート低減用添加剤及び該添加剤を用いたディーゼルエンジン用燃料組成物 |
GB9612331D0 (en) * | 1996-06-13 | 1996-08-14 | Leo Pharm Prod Ltd | Chemical compounds |
CN1222139A (zh) * | 1996-06-13 | 1999-07-07 | 里奥药物制品有限公司 | 多元醇琥珀酸酯及其药物制剂 |
CA2341640A1 (fr) * | 1998-07-02 | 2000-01-13 | Chaitan Khosla | Procedes permettant de fabriquer des polycetides en utilisant des pks modifies |
AUPR059400A0 (en) * | 2000-10-06 | 2000-11-02 | Bar-Ilan University | Formaldehyde-releasing prodrugs |
EP1401850A1 (fr) * | 2001-06-20 | 2004-03-31 | Nuevolution A/S | Derives nucleosidiques pour elaboration de bibliotheque combinatoire |
US7468383B2 (en) * | 2005-02-11 | 2008-12-23 | Cephalon, Inc. | Proteasome inhibitors and methods of using the same |
KR100791844B1 (ko) | 2006-06-30 | 2008-01-07 | 주식회사유한양행 | 메트포르민 또는 그의 염을 함유하는 서방성 제제 및 그의제조방법 |
KR101069502B1 (ko) | 2006-10-31 | 2011-09-30 | (주)아모레퍼시픽 | 비만 및 당뇨병 개선용 경구용 조성물 |
US20120308646A1 (en) * | 2007-01-18 | 2012-12-06 | Hesheng Zhang | Tetracyclic anthraquinones possessing anti-cancer properties |
US8252840B2 (en) | 2007-03-26 | 2012-08-28 | Salutria Pharmaceuticals Llc | Methods of derivatives of probucol for the treatment of type II diabetes |
US8410139B2 (en) * | 2009-10-07 | 2013-04-02 | Bristol-Myers Squibb Company | Prodrugs of a piperidinyl derivative as modulators of chemokine receptor activity |
IT1406068B1 (it) | 2010-07-22 | 2014-02-06 | Medestea Int Spa | Polidesossiribonucleotidi (pdrn) per l'impiego nel trattamento di condizioni di acidosi e composizioni a base di polidesossiribonucleotidi per il suddetto impiego |
JP2014024772A (ja) | 2012-07-25 | 2014-02-06 | Univ Of Tokyo | ミトコンドリアのatp産生能昂進剤 |
ES2661009T3 (es) * | 2012-10-05 | 2018-03-27 | Neurovive Pharmaceutical Ab | Succinatos protegidos para mejorar la producción de ATP mitocondrial |
RS57624B1 (sr) * | 2014-04-08 | 2018-11-30 | Neurovive Pharmaceutical Ab | Nova sukcinatna jedinjenja koja prodiru u ćelije |
EP3129364A1 (fr) | 2014-04-08 | 2017-02-15 | Neurovive Pharmaceutical AB | Promédicaments d'acide succinique pour augmenter la production d'atp |
US10307389B2 (en) | 2014-04-08 | 2019-06-04 | Neurovive Pharmaceutical Ab | Succinate prodrugs for use in the treatment of lactic acidosis or drug-induced side-effects due to Complex I-related impairment of mitochondrial oxidative phosphorylation |
-
2015
- 2015-04-08 RS RS20180921A patent/RS57624B1/sr unknown
- 2015-04-08 CA CA2944565A patent/CA2944565C/fr active Active
- 2015-04-08 US US15/128,480 patent/US11147789B2/en active Active
- 2015-04-08 LT LTEP18175718.8T patent/LT3391941T/lt unknown
- 2015-04-08 MA MA39855A patent/MA39855B1/fr unknown
- 2015-04-08 DK DK15714820.6T patent/DK3129016T3/en active
- 2015-04-08 PL PL15714820T patent/PL3129016T3/pl unknown
- 2015-04-08 ES ES15714820.6T patent/ES2683860T3/es active Active
- 2015-04-08 LT LTEP15714820.6T patent/LT3129016T/lt unknown
- 2015-04-08 MA MA44092A patent/MA44092B1/fr unknown
- 2015-04-08 EA EA201692017A patent/EA035678B1/ru not_active IP Right Cessation
- 2015-04-08 JP JP2016561677A patent/JP7082861B6/ja active Active
- 2015-04-08 KR KR1020167030753A patent/KR102322543B1/ko active IP Right Grant
- 2015-04-08 SI SI201530356T patent/SI3129016T1/sl unknown
- 2015-04-08 MX MX2016012691A patent/MX2016012691A/es unknown
- 2015-04-08 EP EP18175718.8A patent/EP3391941B1/fr active Active
- 2015-04-08 WO PCT/EP2015/057606 patent/WO2015155231A1/fr active Application Filing
- 2015-04-08 TR TR2018/10411T patent/TR201810411T4/tr unknown
- 2015-04-08 PT PT15714820T patent/PT3129016T/pt unknown
- 2015-04-08 ES ES18175718T patent/ES2953522T3/es active Active
- 2015-04-08 EP EP15714820.6A patent/EP3129016B1/fr active Active
- 2015-04-08 AU AU2015243346A patent/AU2015243346C9/en active Active
- 2015-04-08 PT PT181757188T patent/PT3391941T/pt unknown
- 2015-04-08 CN CN201580021727.0A patent/CN106458957B/zh active Active
- 2015-04-08 SG SG11201607907PA patent/SG11201607907PA/en unknown
-
2016
- 2016-09-19 IL IL247904A patent/IL247904B/en active IP Right Grant
- 2016-09-23 ZA ZA2016/06608A patent/ZA201606608B/en unknown
-
2018
- 2018-07-16 HR HRP20181126TT patent/HRP20181126T1/hr unknown
- 2018-08-27 CY CY181100892T patent/CY1120650T1/el unknown
- 2018-11-08 HK HK18114264.0A patent/HK1255109A1/zh unknown
- 2018-12-19 AU AU2018282308A patent/AU2018282308B2/en active Active
-
2020
- 2020-02-06 JP JP2020018467A patent/JP7229189B2/ja active Active
-
2021
- 2021-07-20 JP JP2021119885A patent/JP2021169519A/ja active Pending
- 2021-07-20 JP JP2021119813A patent/JP2021169518A/ja active Pending
- 2021-09-14 US US17/474,482 patent/US20210401792A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA44092B1 (fr) | Nouveaux composés de succinate perméables à travers les cellules | |
MX2016012752A (es) | Profarmacos de acido succinico para incrementar la produccion de adenosina trifosfato (atp). | |
CY1122454T1 (el) | Στερεες δοσολογικες μορφες palbociclib | |
RU2012122025A (ru) | Плюрипотентные стволовые клетки | |
GB2548740A (en) | Methods for generation of podocytes from pluripotent stem cells and cells produced by the same | |
PE20210922A1 (es) | Pirimidinonas como inhibidores del factor xia | |
BR112017000721A2 (pt) | eléctrodo para a produção de divisão de água, eletrolisador de água, célula cloro alcalina e respectivo método de fabrico | |
CY1123893T1 (el) | Αμιδια πυρρολης ως αναστολεις ιντεγκρινων αλφα v | |
MX2018009493A (es) | Uso combinado de al menos una endoproteasa y al menos una exoproteasa en un proceso simultaneo de sacarificacion y fermentacion (ssf) para mejorar la produccion de etanol. | |
TWD206404S (zh) | 太陽能電池 | |
WO2015162594A3 (fr) | Thérapie génique | |
UY36213A (es) | “aumento de la cosecha (rendimiento) de plantas de cultivo utilizando leyes termodinámicas en plantas completas para detectar períodos óptimos para necesidades de energía exotérmica en comparación con energía endotérmica”. | |
EA201692154A1 (ru) | Перорально распадающаяся пленка | |
UY38134A (es) | Reducción de la producción de acetato mediante levadura que sobreexpresa pab1 | |
ES2914357T3 (es) | Nueva línea celular y usos de la misma | |
CL2017003223A1 (es) | Proceso para la estabilización de mercurio metálico | |
CL2021000663A1 (es) | Proceso para la producción de gas de síntesis. | |
PH12017501111B1 (en) | Novel acetals of 1-(3,3-dimethylcyclohex-1-enyl) ethanone, method for production thereof and use of same in perfumery | |
PE20221009A1 (es) | Sintesis de un inhibidor de calicreina plasmatica a escala de proceso | |
FR3021668B1 (fr) | Augmentation de la recombinaison meiotique chez les plantes par inhibition d'une proteine recq4 ou top3a du complexe rtr | |
RU2017139241A (ru) | Способ получения клона стволовых клеток, пригодного для индуцирования дифференцировки в соматические клетки. | |
MA38379A1 (fr) | Synthese d'un nouveau materiau : phosphite de titane ti2(hpo3)3 | |
JP1725622S (ja) | マルチチャンネル分光器 | |
JP1761285S (ja) | うがい用コップ | |
JP1743836S (ja) | オフィスの内装 |